San Rocco Therapeutics Gains Bipartisan Support for Affordable Sickle Cell Cure
In a rare show of unity, San Rocco Therapeutics is being praised across the political spectrum for its mission to deliver a safe and accessible gene therapy for sickle cell disease. With backing from both Republican and Democratic leaders, the company stands out for challenging high-cost pharma models and putting…